Latest Breaking News On - Martin mccarter - Page 1 : comparemela.com

CU study proves effectiveness of new multidrug treatment for patients with stage IV melanoma

A new multidrug treatment for patients with stage IV melanoma has proven effective after a three-year clinical trial at the University of Colorado Cancer Center.

United statesMartin mccarterEmily hendersonUniversity of colorado school medicineUniversity of colorado cancer centerCu cancer centerClinical cancer researchColorado cancerSurgical oncologyColorado schoolDiscovery industry focusClinical trialImmune systemSkin cancer

Melanoma Clinical Trial Reveals Success of Drug Combination

A combination of a common immunotherapy drug with all-trans retinoic acid, a chemotherapeutic, has shown promise in clinical trials.

United statesMartin mccarterUniversity of colorado school medicineUniversity of colorado cancer centerCu cancer centerClinical cancer researchColorado cancerColorado school

Drug Combo Proves Effective for Melanoma in Trial at CU Cancer Center

Drug Combo Proves Effective for Melanoma in Trial at CU Cancer Center
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

United statesMartin mccarterUniversity of colorado school medicineUniversity of colorado cancer centerCu cancer centerClinical cancer researchColorado cancerColorado school

Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting

Iovance Biotherapeutics Announces Updated Clinical Data for Lifileucel in Advanced Melanoma at Society for Immunotherapy of Cancer (SITC) Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMartin mccarterJen saundersdirectorMiguel peralesFriedrich graf finckensteinAllison betof warnerAmod sarnaikSara pellegrinoIovance biotherapeutics incAdult bone marrow transplant serviceSociety for immunotherapy of cancerProgram development department of surgeryH lee moffitt cancer centerDrug administrationUniversity of colorado cancer centerPanel webcast

A potential way for overcoming immunotherapy resistance in patients with mucosal melanomas

The development of the anti-cancer immunotherapy drugs called immune checkpoint inhibitors has improved treatment for many cancer patients, but patients with mucosal melanomas -; melanomas that occur not on the skin but in the mucous membranes in the head, neck, eyes, respiratory tract, and genitourinary region -; are particularly resistant to immune checkpoint inhibitors for reasons researchers don't fully understand.

United statesMartin mccarterRichard tobinTheresa medinaEmily hendersonCu centerUniversity of colorado cu cancer centerUniversity of colorado school medicineCu cancer centerNational comprehensive cancer networkCancer centerYoung investigator awardColorado schoolKasey coutsAncer immunotherapyClinical trial